Role of Erbitux plus a combination of CPT-11/5-fluorouracil/leucovorin/oxaliplatin as neoadjuvant chemotherapy in patients with colorectal liver metastases
- Registry ID
- EUCTR2005-006205-28
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- ISTITUTI FISIOTERAPICI OSPITALIERI
- Start date
- 2006-04-15
- Last update
- 2026-08-16
Conditions
- Liver metastases from colorectal cancer
Summary
To investigate the rate of patients submitted to surgery for liver metastases after a triplet induction chemotherapy (CPT-11, 5-fluorouracil-leucovorin, oxaliplatin) plus Erbitux in patients with liver metastases from colorectal cancer
Locations
View on source registry